UBS Starts Ortho Clinical Diagnostics (OCDX) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to UBS Starts Ortho Clinical Diagnostics (OCDX) at Buy

Morgan Stanley Starts Ortho Clinical Diagnostics (OCDX) at Overweight

February 22, 2021 3:08 AM EST

Morgan Stanley analyst Tejas Savant initiates coverage on Ortho Clinical Diagnostics (NASDAQ: OCDX) with a Overweight rating and a price target of $24.00.


For an analyst ratings summary and ratings history on Ortho Clinical Diagnostics... More

Goldman Sachs Starts Ortho Clinical Diagnostics (OCDX) at Buy

February 22, 2021 1:19 AM EST

Goldman Sachs analyst Matthew Sykes initiates coverage on Ortho Clinical Diagnostics (NASDAQ: OCDX) with a Buy rating and a price target of $27.00.


For an analyst ratings summary and ratings history on Ortho Clinical Diagnostics... More

JPMorgan Starts Ortho Clinical Diagnostics (OCDX) at Overweight

February 22, 2021 12:47 AM EST

JPMorgan analyst Tycho Peterson initiates coverage on Ortho Clinical Diagnostics (NASDAQ: OCDX) with a Overweight rating and a price target of $25.00.


For an analyst ratings summary and ratings history on Ortho Clinical Diagnostics... More